Shenyang Dasan Pharmaceutical Technology Co., Ltd.



HOME
ABOUT US 
- Profile
- History
- Culture
- Organization
- Honors
- Partner
MAIN BUSINES 
TECHNOLOGY 
PROJECTS 
NEWS 
- Company news
- Industry news
CONTACT US 
- Contact
- Jobs
- Message

中

1

11

医疗行业

Previous 

Next 

ABOUT US

Shenyang Dasan Pharmaceutical Technology Co., Ltd. is a high-tech enterprise whose main research direction is the development and industrialization of oral complex preparations. It has invested more than 8 million yuan to build multiple complex preparation development and industrial technology development platforms.

MORE

TECHNOLOGY PLATFORM

CORE TECHNOLOGIES

MORE

CORE COMPETENCE

MORE

PROJECT DISPLAY

Complete Project

MORE

Research Projects

MORE

Project

MORE

NEWS CENTER

2020

12-11

Our customer Daewon Pharm Co., Ltd “Pelubiprofen CR Tablets ,Pelubi®” obtained CTA

MORE >

2020

11-26

Our customer Fuzhou Minhai Pharmaceutical “Roxatidine Acetate Hydrochloride Extended-release Capsules” obtained CTA

2020

09-10

The Ministry of Industry and Information Technology's 2019 China Pharmaceutical Industry Top 100 list is authoritatively released!

2020

09-10

CDE release: Technical guidelines for research on production technology of Chinese medicine compound preparations (draft for comments)

In order to speed up the establishment and improvement of an evaluation technology evaluation system that meets the characteristics of traditional Chinese medicine, and guide applicants to rationally conduct research on the production process of traditional Chinese medicine compound preparations, our center organized the drafting of the "Technical Guidelines for the Production Process Research of Chinese Medicine Compound Preparations", which has been drafted for soliciting opinions. Now the center website is publicized to listen to opinions and suggestions from all walks of life.

PARTNER

Dasan Pharmaceutical has an API R&D center in Shanghai, and has established strategic partnerships with Shenyang Pharmaceutical University, Shanghai Institute of Medicine of Chinese Academy of Sciences, East China University of Science and Technology, National University of Singapore and other research institutions and universities to provide customers with a full range of drug R&D services .